New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2013
16:00 EDTOPKOPKO citicoline products approved for commercialization in Spain
OPKO Health announced that its Barcelona, Spain subsidiary, Pharmadiet, S.L.U., received regulatory approval from Spainís health authority for commercialization of its oral and injectable formulations of citicoline. Final marketing authorization is expected within 60 to 90 days.
News For OPK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
08:47 EDTOPKOPKO Health in exchange pacts with holder of 3.00% convertible senior notes
OPKO Health disclosed in a regulatory filing that on or around March 23 the company entered into two exchange agreements with a holder of the companyís 3.00% convertible senior notes due 2033 pursuant to which such holder agreed to exchange approximately $36.4M in aggregate principal amount of notes for 5,363,896 shares of the companyís common stock and approximately $168,000 in cash representing accrued interest through the date of completion of the exchange. The company expects to complete the exchanges on or around March 27.
March 27, 2015
09:13 EDTOPKOPKO Health to present phase 3 Rayaldee data, says supports company conclusions
Subscribe for More Information
March 26, 2015
06:33 EDTOPKOPKO Health assumed with an Outperform at Barrington
Target $19.
05:50 EDTOPKStocks with implied volatility movement; OPK XLK
Stocks with implied volatility movement; OPKO Health (OPK) 58, Technology Select Sector SPDR (XLK) 17 according to iVolatility.
March 23, 2015
09:09 EDTOPKOPKO Health reports SciVac enters transaction with Levon
Subscribe for More Information
07:32 EDTOPKTiger Media completes acquisition of Interactive Data
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use